Business
– Teva has lost its 180 days exclusivity for the generic version of Pfizer’s arthritis and chronic pain treatment. – The US Supreme...
Hi, what are you looking for?
– Teva has lost its 180 days exclusivity for the generic version of Pfizer’s arthritis and chronic pain treatment. – The US Supreme...
– “We are upgrading our recommendation for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) from “Market perform” to “Market outperform” with a target...
– Novartis will invest $10 million in BioLineRX for a 12.8% stake. They will select three projects for joint development. – Drug development...
– Generic competition for Copaxone and foreign currency volatility will hit Teva’s sales. – When Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA)...
– The decision gives Teva more time to transfer patients to its better patent protected double dosage Copaxone. – Teva Pharmaceutical Industries Ltd. (NYSE:...
This could well be the foundation for a romantic novel: Nam, 40, who was born in a Thai village without electricity and running...
– Teva is battling generic versions of the 20 mg and 40 mg dosages of its MS blockbuster. – In the absence of...
– Sales of the multiple sclerosis treatment were down 12% in the second quarter. – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) reported...
– According to a recent SEC filing, reported by Economic Policy Journal, the largest stake held by the George Soros Fund Management is a...
– – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) has reached settlements with Sandoz, Actavis, Lupin and Apotex with respect to U.S. Patent 7, 132, 570...